Hepatic Encephalopathy
&nbsp;
Hepatic Encephalopathy (HE) is a brain disorder that develops in some individuals with liver disease. HE presents as a spectrum of neuropsychiatric symptoms ranging from subtle fluctuating cognitive impairment to coma and is a significant contributor to morbidity in patients with liver disease. It is observed in acute liver failure, liver bypass procedures &ndash; for example, shunt surgery and trans-jugular intrahepatic portosystemic shunt &ndash; and cirrhosis, classified as Type A, B, and CHE, respectively. Pathogenesis is linked with ammonia and glutamine production.
&nbsp;
Hepatic Encephalopathy Epidemiology Segmentation in the 7MM
&nbsp;
<ul>
<li class="ql-align-justify">Total Diagnosed Prevalent Cases of Hepatic Encephalopathy</li>
<li class="ql-align-justify">Gender-specific Diagnosed Prevalent Cases of Hepatic Encephalopathy</li>
<li class="ql-align-justify">Age-specific Diagnosed Prevalent Cases of Hepatic Encephalopathy</li>
<li class="ql-align-justify">Type-specific Diagnosed Prevalent Cases of Hepatic Encephalopathy</li>
</ul>
&nbsp;
&nbsp;
<a style="color: #1155cc; background-color: transparent;" href="https://www.delveinsight.com/report-store/hepatic-encephalopathy-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Hepatic Encephalopathy Epidemiological Insights</a> Observed in the 7MM (2021)
&nbsp;
<ul>
<li class="ql-align-justify">The total incident cases of Hepatic Encephalopathy observed in the 7MM were observed to be 337K cases in the year 2021</li>
<li class="ql-align-justify">The highest diagnosed Hepatic Encephalopathy population accounting for 205K cases, was found in the United States in the year 2021</li>
<li class="ql-align-justify">Amongst EU5, the prevalence in the UK was observed to be 28.2K cases, whereas, in Germany, it was 26.6K cases and 22.3K cases in France.&nbsp;</li>
<li class="ql-align-justify">In EU5, the lowest prevalence was in Spain, which was 9.3K cases. Whereas in Italy, it was 16K cases.&nbsp;</li>
<li class="ql-align-justify">The total incident cases of Hepatic Encephalopathy observed in Japan was 29.4K cases.&nbsp;</li>
<li class="ql-align-justify">The type-specific Hepatic Encephalopathy diagnosed cases observed in the United States were observed to be 123K cases of Covert Hepatic Encephalopathy and &nbsp;82.2K cases of Overt Hepatic Encephalopathy&nbsp;</li>
</ul>
&nbsp;
<a style="color: #1155cc; background-color: transparent;" href="https://www.delveinsight.com/report-store/hepatic-encephalopathy-market" target="_blank" rel="noopener noreferrer">Hepatic Encephalopathy Market Insight</a>
&nbsp;
The market size of Hepatic Encephalopathy in the 7MM was found to be approximately USD 1,563 million in 2021. &nbsp;
&nbsp;
Hepatic Encephalopathy Market Strengths
&nbsp;
<ul>
<li class="ql-align-justify">The increasing prevalent population of the disease is likely to cause a surge in treatment options, and consequently, the market might witness a boost in upcoming years</li>
</ul>
&nbsp;
Hepatic Encephalopathy Market Opportunities
&nbsp;
<ul>
<li class="ql-align-justify">Medications with better safety and effectiveness, which provide an optimum cure, are the current unmet need of the HE disease market.</li>
</ul>
&nbsp;
<a style="color: #1155cc; background-color: transparent;" href="https://www.delveinsight.com/report-store/hepatic-encephalopathy-pipeline-insight" target="_blank" rel="noopener noreferrer">Hepatic Encephalopathy Emerging Drugs</a>
&nbsp;
The emerging drugs in the Hepatic Encephalopathy market are
<ul>
<li class="ql-align-justify">AXA1665</li>
<li class="ql-align-justify">GR3027 (Golexanolone)</li>
<li class="ql-align-justify">RBX 2660</li>
<li class="ql-align-justify">VE303, and others</li>
</ul>
&nbsp;
Hepatic Encephalopathy Key Players&nbsp;
&nbsp;
The key players working in the Hepatic Encephalopathy market are
&nbsp;
<ul>
<li class="ql-align-justify">Axcella Health, Inc.</li>
<li class="ql-align-justify">Umecrine Cognition</li>
<li class="ql-align-justify">Rebiotix</li>
<li class="ql-align-justify">Vedanta Biosciences</li>
<li class="ql-align-justify">Patricia Bloom, and others</li>
</ul>

Hepatic Encephalopathy Market

Hepatic Encephalopathy Symptoms, Treatment, epidemiology, companies, drugs, an infographic is a short guide to understand the problem and market landscape